// <auto-generated/>
// Contents of: hl7.fhir.r4.core version: 4.0.1
// Minimum TypeScript Version: 3.7
// FHIR ValueSet Enum: http://hl7.org/fhir/ValueSet/research-study-phase|4.0.1

/**
 * Codes for the stage in the progression of a therapy from initial experimental use in humans in clinical trials to post-market evaluation.
 */
export enum ResearchStudyPhaseValueSetEnum {
  /**
   * early-phase-1: Designation for optional exploratory trials conducted in accordance with the United States Food and Drug Administration's (FDA) 2006 Guidance on Exploratory Investigational New Drug (IND) Studies. Formerly called Phase 0.
   */
  EarlyPhase1 = "early-phase-1",
  /**
   * n-a: Trials without phases (for example, studies of devices or behavioral interventions).
   */
  NA = "n-a",
  /**
   * phase-1: Includes initial studies to determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and to gain early evidence of effectiveness; may include healthy participants and/or patients.
   */
  Phase1 = "phase-1",
  /**
   * phase-1-phase-2: Trials that are a combination of phases 1 and 2.
   */
  Phase1Phase2 = "phase-1-phase-2",
  /**
   * phase-2: Includes controlled clinical studies conducted to evaluate the effectiveness of the drug for a particular indication or indications in participants with the disease or condition under study and to determine the common short-term side effects and risks.
   */
  Phase2 = "phase-2",
  /**
   * phase-2-phase-3: Trials that are a combination of phases 2 and 3.
   */
  Phase2Phase3 = "phase-2-phase-3",
  /**
   * phase-3: Includes trials conducted after preliminary evidence suggesting effectiveness of the drug has been obtained, and are intended to gather additional information to evaluate the overall benefit-risk relationship of the drug.
   */
  Phase3 = "phase-3",
  /**
   * phase-4: Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
   */
  Phase4 = "phase-4",
}
